Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
Advanced or metastatic Bladder / Urothelial Cancer, Biliary Tract Cancer (cholangiocarcinoma), and NSCLC.
Biliary tract cancer, Relapsed Non-Hodgkin Lymphoma, and Pancreatic Cancer.
Targeted treatment of solid tumors and hematologic malignancies.